# OnCo record numiera-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/numiera-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "numiera-therapeutics" ;
  schema:name "Numiera Therapeutics"@en ;
  schema:alternateName "Numiera Therapeutics Inc"@en, "Numiera Therapeutics, Inc."@en ;
  schema:description "Numiera Therapeutics is a Colorado company repurposing etomoxir, an older heart-failure drug, to cut off the fat-burning energy supply that glioblastoma cells rely on. It holds an FDA orphan designation for malignant glioma."@en ;
  schema:url <https://onco.cc/companies/numiera-therapeutics/>, <https://www.numiera.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.numiera.com/>, <https://www.numiera.com/etomoxir>, <https://reporter.nih.gov/project-details/11314195> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/metabolic-therapy/> ;
  onco:drugs <https://onco.cc/drugs/etomoxir/> .